Phase 4 Heart Disease Trial, Recruiting (NCT06068764)

Phase 4 Heart Disease Trial, Recruiting NCT06068764 Sponsor: Hartford Hospital Condition: Heart Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06068764 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Heart Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are scheduled for a planned (non-emergency) open heart bypass surgery (CABG)
You have been given a general health rating between I and IV by your anesthesia team (this covers a wide range of health conditions)
You are able to speak and read both English and Spanish

Who may not be able to join:

Your bypass surgery is an emergency, urgent, or last-minute procedure
You do not wish to give consent, or are unable to give consent to take part in the study
You have a known condition where your adrenal glands do not produce enough hormones (confirm with trial site)
You are currently experiencing any type of shock, such as from infection, blood loss, or heart failure
You have been taking steroid medications (such as prednisone or similar drugs) at any point in the 6 months before your surgery
You have a known allergy to either etomidate or propofol (medications used during anesthesia)
You have a known seizure disorder or history of seizures
You are already taking part in another clinical research study that may interfere with this one

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 5 July 2026

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Joseph Hinchey, MD, Hartford Hospital

Phone: 860-972-1778

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06068764

Sponsor: Hartford Hospital

Phase: Phase 4

Status: Recruiting

Condition: Heart Disease

Trial contact: 860-972-1778

More information: https://clinicaltrials.gov/study/NCT06068764

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are scheduled for a planned (non-emergency) open heart bypass surgery (CABG)
You have been given a general health rating between I and IV by your anesthesia team (this covers a wide range of health conditions)
You are able to speak and read both English and Spanish

Who may not be able to join:

Your bypass surgery is an emergency, urgent, or last-minute procedure
You do not wish to give consent, or are unable to give consent to take part in the study
You have a known condition where your adrenal glands do not produce enough hormones (confirm with trial site)
You are currently experiencing any type of shock, such as from infection, blood loss, or heart failure
You have been taking steroid medications (such as prednisone or similar drugs) at any point in the 6 months before your surgery
You have a known allergy to either etomidate or propofol (medications used during anesthesia)
You have a known seizure disorder or history of seizures
You are already taking part in another clinical research study that may interfere with this one

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 5 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 4

Sponsor

Hartford Hospital

Registry

ClinicalTrials.gov

Start date

5 December 2023

Est. completion

1 December 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Vasopressors dose expressed by Noradrenaline Equivalent dose [μg/kg/min]

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov